Medicine put to the test

The independent Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) examines the benefits and harms of medical interventions for patients. We provide information about the advantages and disadvantages of examination and treatment methods in the form of scientific reports and easily understandable health information.

Latest news

Press Releases

Press Releases

Early benefit assessment reveals weaknesses in the development of new drugs

2019-07-11 In the British Medical Journal, IQWiG researchers analyse the first 216 AMNOG assessments of new drugs and derive proposals for more targeted drug development.

read more Link to \Early benefit assessment reveals weaknesses in the development of new drugs\""

Tumour treating fields in glioblastoma: indication of a benefit

2019-06-25 The additional application of the new treatment method prolongs survival, as a recent study shows. However, it can also be burdensome for patients.

read more Link to \Tumour treating fields in glioblastoma: indication of a benefit\""

Fingolimod: advantages for children and adolescents with highly active RRMS requiring treatment switch

2019-06-21 New analyses in an addendum confirm hint of an added benefit in one of four research questions. Especially with regard to quality of life, usable data are now available.

read more Link to \Fingolimod: advantages for children and adolescents with highly active RRMS requiring treatment switch\""

16th HTAi Annual Meeting 2019, Cologne: international experts look into the future of HTA

2019-06-04 In two weeks' time, the 16th HTAi Annual Meeting will start in Cologne: globalization and digitalization also call for adequate methods and effective action in health technology assessment. IQWiG is a…

read more Link to \16th HTAi Annual Meeting 2019, Cologne: international experts look into the future of HTA\""

Allogeneic stem cell transplantation in non-Hodgkin lymphoma: benefit remains unclear

2019-05-21 Meaningful studies are lacking for certain patient groups. Disease-specific registries could help close the data gap.

read more Link to \Allogeneic stem cell transplantation in non-Hodgkin lymphoma: benefit remains unclear\""

Nivolumab with ipilimumab: drug combination has added benefit in advanced renal cell carcinoma

2019-05-15 There are advantages in overall survival, which are not offset by any disadvantages of similar importance. Extent of the added benefit depends on the patient risk scores.

read more Link to \Nivolumab with ipilimumab: drug combination has added benefit in advanced renal cell carcinoma\""

Blister packaging for drugs in nursing homes: much discussed, but hardly investigated

2019-05-14 Data are lacking for arguments on the pros and cons, as the available studies examine the outpatient sector. IQWiG proposes a design for a new study.

read more Link to \Blister packaging for drugs in nursing homes: much discussed, but hardly investigated\""

Apalutamide in prostate cancer: indication of considerable added benefit

2019-05-02 Symptomatic progression is significantly retarded by this drug. This advantage clearly outweighs the disadvantages presented by some side effects.

read more Link to \Apalutamide in prostate cancer: indication of considerable added benefit\""

How NNTs can be graphically illustrated in network meta-analyses

2019-04-25 In the Journal of Clinical Epidemiology, an international team of authors discusses the possibilities and limitations of graphical representations of statements on absolute effects.

read more Link to \How NNTs can be graphically illustrated in network meta-analyses\""

Ribociclib in advanced breast cancer: survival advantages, accompanied by severe side effects

2019-04-15 Study indicates longer overall survival of postmenopausal women. However, there is a higher frequency of severe diseases of blood and lymphatic system. Overall, added benefit not proven.

read more Link to \Ribociclib in advanced breast cancer: survival advantages, accompanied by severe side effects\""

Current commenting procedures (Hearings)

Current commenting procedures (Hearings)

There are no actual comments.


Calls for tenders advertised

Calls for tenders advertised

In general, calls for tenders are published in German. Interested parties can check current calls for tenders on the German website.


Easily understandable information for patients and the general community

Osteoarthritis of the knee

Osteoarthritis of the knee typically starts with knee pain, at first only during or after movement. The risk is increased by things like being overweight or putting a lot of strain on your knees, for example if you kneel a lot. If osteoarthritis is advanced or can’t be relieved enough by exercise or painkillers, joint replacement may be considered.   read more (Link to \Osteoarthritis of the knee\"" ‚Äì opens in a new window)


Save result list

To save your search result, please copy the link below and paste it into a new tab/window.

close